Weight loss · Buffalo, NY
Weight loss and obesity studies in Buffalo, NY
7 recruiting studies have a site in Buffalo.
7 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Hoffmann-La Roche
- Location
- Buffalo, NY + 43 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Eli Lilly and Company
- Location
- Buffalo, NY + 37 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Eli Lilly and Company
- Location
- Buffalo, NY + 22 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Eli Lilly and Company
- Location
- Buffalo, NY + 28 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
Blood Collection Biorepository for Liver Disease Research
State University of New York at Buffalo
- Location
- Buffalo, NY
- Eligibility basics
- Ages 7+
- RecruitingHealthy volunteers
Maternal Smoking Cessation and Pediatric Obesity Prevention
State University of New York at Buffalo
- Location
- Buffalo, NY
- Eligibility basics
- Ages 18–39 · Women only
- RecruitingHealthy volunteers
Developmental Trajectories of Reinforcer Pathology and Childhood Obesity
State University of New York at Buffalo
- Location
- Buffalo, NY
- Eligibility basics
- Ages 8–11
Who these studies look for
Most of these studies set a BMI range and may exclude people taking certain weight-loss medicines or who have had bariatric surgery. Some require a weight-related condition such as type 2 diabetes or high blood pressure.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.